New York, NY
Dr. Andrea S. Wolf
Princeton University, Princeton, NJ - 1998
Harvard Medical School, Boston, MA - 2003
Massachusetts General Hospital, Boston, MA (2003-2008)
Brigham and Women's Hospital, Harvard Medical School, Boston, MA (2008-2010)
Dr. Andrea S. Wolf is an assistant professor of thoracic surgery at the Icahn School of Medicine at Mount Sinai located in New York, New York. In addition to her academic post, Dr. Wolf is the director of the newly founded Women’s Lung Cancer Program at The Mount Sinai Hospital. This program encompasses clinical research, community outreach and education, and a multidisciplinary approach to the treatment of lung cancer in women. Prior to joining the faculty at Mount Sinai in 2012, Dr. Wolf served as chief resident in thoracic surgery at Brigham and Women’s Hospital in Boston, Massachusetts.
Dr. Wolf graduated from Princeton University located in Princeton, New Jersey with a bachelor of arts degree in 1998 before moving on to earn her medical degree in 2003 at Harvard Medical School in Boston, Massachusetts. She completed her residency in general surgery at Massachusetts General Hospital in Boston from 2003 through 2008 followed by a fellowship in thoracic surgery at Brigham and Women's Hospital and Harvard Medical School from 2008 through 2010. During that span of time, Dr. Wolf also earned a master’s degree in public health (MPH) in the area of clinical effectiveness at the Harvard University School of Public Health in 2010. She completed a residency in cardiothoracic surgery at Brigham and Women's Hospital and Harvard Medical School from 2010 through 2012 after which she relocated to New York to assume her position at Mount Sinai.
Clinical and Laboratory Research
Dr. Wolf’s clinical focus is on the management of malignancies relative to the lungs, including mesothelioma, lung cancer, esophageal cancer, and mediastinal tumors. While training in Boston, Dr. Wolf developed an interest in treating mesothelioma patients and educating both her colleagues in the medical community and the public about this challenging disease state. Over the years, this interest evolved into Dr. Wolf making mesothelioma a primary focus on her career path. She has authored and co-authored several mesothelioma studies and research articles in well-respected medical journals, including one study published in The Annals of Thoracic Surgery in 2014 which showed far better survival rates in women with malignant pleural mesothelioma over men. When asked to comment on the current standard of care for mesothelioma patients, Dr. Wolf replied: “The challenge is that there is no standard of care for mesothelioma.” Dr. Wolf’s hope is that her research will contribute to the determination of what that standard should be. When asked how she envisions the standard to progress over the next 10 years, Dr. Wolf stated: “Over the next 10 years, I anticipate progress in adjuvant therapies to prevent progression and recurrence of disease, including novel immunologic, biologic, and hormonal treatments.”
Dr. Wolf is board-certified in general surgery and thoracic surgery. She is particularly skilled in robotic surgery and minimally-invasive techniques such as video-assisted thoracic and laparoscopic surgery for the treatment of both malignant and benign diseases.
Dr. Wolf’s most recent publications relative to mesothelioma treatment and research include the following:
Taioli E, Wolf AS, Moline JM, Camacho-Rivera M, Flores RM. Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma. Dis Markers. 2015;2015:282145. Epub 2015 Apr 30.
Taioli E, Wolf AS, Flores RM. Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma. Ann Thorac Surg. 2015 Feb;99(2):472-80. Epub 2014 Dec 20.
Wolf AS, Flores RM. Extrapleural pneumonectomy for pleural malignancies. Thorac Surg Clin. 2014 Nov;24(4):471-5. Epub 2014 Oct 23. Review.
Taioli E, Wolf AS, Camacho-Rivera M, Flores RM. Women with malignant pleural mesothelioma have a threefold better survival rate than men. Ann Thorac Surg. 2014 Sep;98(3):1020-4. Epub 2014 Jun 11.
Lim JY, Wolf AS, Flores RM. The use of surgery in mesothelioma. Lancet Respir Med. 2013 May;1(3):184-6. Epub 2013 Mar 29.
Sugarbaker DJ, Gill RR, Yeap BY, Wolf AS, DaSilva MC, Baldini EH, Bueno R, Richards WG. Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection. J Thorac Cardiovasc Surg. 2013 Apr;145(4):955-63. Epub 2013 Feb 21.
Gill RR, Richards WG, Yeap BY, Matsuoka S, Wolf AS, Gerbaudo VH, Bueno R, Sugarbaker DJ, Hatabu H. Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume. AJR Am J Roentgenol. 2012 Feb;198(2):359-63.
Sugarbaker DJ, Wolf AS, Chirieac LR, Godleski JJ, Tilleman TR, Jaklitsch MT, Bueno R, Richards WG. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy. Eur J Cardiothorac Surg. 2011 Aug;40(2):298-303. Epub 2011 Feb 9.
Wolf AS, Richards WG, Tilleman TR, Chirieac L, Hurwitz S, Bueno R, Sugarbaker DJ. Characteristics of malignant pleural mesothelioma in women. Ann Thorac Surg. 2010 Sep;90(3):949-56; discussion 956.
Sugarbaker DJ, Wolf AS. Surgery for malignant pleural mesothelioma. Expert Rev Respir Med. 2010 Jun;4(3):363-72.
Wolf AS, Jacobson FL, Tilleman TR, Colson Y, Richards WG, Sugarbaker DJ. Managing the pneumonectomy space after extrapleural pneumonectomy: postoperative intrathoracic pressure monitoring. Eur J Cardiothorac Surg. 2010 Apr;37(4):770-5. Epub 2010 Jan 6.
Wolf AS, Daniel J, Sugarbaker DJ. Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication. Semin Thorac Cardiovasc Surg. 2009 Summer;21(2):132-48.Sources